| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.01 |